Forcyte Biotechnologies is focused on the discovery of drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma.